C12N 2740/16062
By genetic engineering
Official title: by genetic engineering
C12N2740/16062 (By genetic engineering) appears on 42 US grants and 47 published applications in this corpus.
Search patents in C12N- Granted patents
- 42
- Published applications
- 47
- Assignees
- 36
- Inventors
- 83
- Latest grant
- 21 Nov 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 0 |
| 2002 | 2 | 5 |
| 2003 | 1 | 2 |
| 2004 | 4 | 2 |
| 2005 | 0 | 3 |
| 2006 | 3 | 3 |
| 2007 | 1 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 3 | 3 |
| 2011 | 1 | 0 |
| 2012 | 2 | 6 |
| 2013 | 4 | 0 |
| 2014 | 2 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 3 |
| 2017 | 0 | 3 |
| 2018 | 0 | 3 |
| 2019 | 0 | 0 |
| 2020 | 3 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 2 | 2 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Editing of CCR2 receptor gene to protect against HIV infection21 Nov 2023US 11,820,969 B2President and Fellows of Harvard College
- Methods and compositions for generating a deletion library and for identifying a defective interfering particle (DIP)21 Feb 2023US 11,584,931 B2The J. David Gladstone Institutes
- Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays4 Oct 2022US 11,459,624 B2Monogram Biosciences, Inc.
- Non-integrating HIV-1 comprising mutant RT/IN proteins and the SARS-CoV-2 spike protein28 Sep 2021US 11,129,890 B1Vigene Biosciences, Inc.
- Editing of CCR5 receptor gene to protect against HIV infection18 Aug 2020US 10,745,677 B2President and Fellows of Harvard College
- Tat-induced crispr/endonuclease-based gene editing7 Aug 2025US 2025/0250562 A1Temple University of the Commonwealth System of Higher Education
- Editing of ccr5 receptor gene to protect against hiv infection4 Apr 2024US 2024/0110166 A1President and Fellows of Harvard College
- Methods and compositions for generating a deletion library and for identifying a defective interfering particle (dip)1 Feb 2024US 2024/0035021 A1The J. David Gladstone Institutes
- Compositions and Methods for Determining Resistance to Inhibitors of Virus Enter Using Recombinant Virus Assays5 Oct 2023US 2023/0313327 A1Monogram Biosciences, Inc.
- Tat-induced crispr/endonuclease-based gene editing22 Jun 2023US 2023/0193257 A1Temple University of the Commonwealth System of Higher Education
Most cited
By later US patents
- Vector and method of use for nucleic acid delivery to non-dividing cells323US 6,013,516 AThe Salk Institute for Biological Studies · 2000
- Use of triplex structure DNA in transferring nucleotide sequences98US 6,682,907 B1Institut Pasteur · 2004
- Ribonuclease resistant RNA preparation and utilization80US 5,939,262 AAmbion, Inc. · 1999
- Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof65US 5,665,577 ADana-Farber Cancer Institute, Inc. · 1997
- Editing of CCR5 receptor gene to protect against HIV infection62US 10,745,677 B2President and Fellows of Harvard College · 2020